Burgess Julie 4
4 · Design Therapeutics, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-02+110,000→ 110,000 totalExercise: $2.54Exp: 2034-01-01→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2025, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.